NFKB1 and respiratory system disorder: Implementing therapeutic strategies based on the regulation of miR-9 and NF-κB signaling could, in fact, reduce inflammation and significantly improve the clinical management of a wide range of respiratory diseases, although further research is needed to validate these applications.